Eurofins strengthens Asia Pacific footprint with the acquisition of New Zealand Laboratory Services

04-Jul-2012

Eurofins Scientific announced that it has acquired New Zealand Laboratory Services (NZ Labs). NZ Labs generated revenues of over EUR 5m in 2011 and employs around 100 staff across 3 strategically-located laboratories spanning the whole of New Zealand. The domestic food testing market serves primarily the dairy and meat sectors of the food industry, with the majority of produce from these sectors bound for export.

The entry into New Zealand is consistent with the Group’s commitment in the rapidly-growing Asia Pacific region. Given NZ Labs’ existing nationwide coverage, the roll-out of Eurofins’ technology and capabilities, and the transfer of know-how should be reasonably quick, allowing the Group to participate actively in this growing food market.

Gilles Martin, Eurofins CEO, commented: “NZ Labs is an excellent strategic fit with Eurofins’ growing Asia Pacific presence and provides a solid entry into the thriving food industry in that region. Specifically, it provides a strong regional platform for the Group’s capabilities in dairy and pesticides testing. We are looking forward to strengthening NZ Labs’ position in the market by offering the full range of services and capabilities of the Eurofins Group.”

Facts, background information, dossiers
More about Eurofins
  • News

    Eurofins acquires BioDiagnostics, Inc.

    Eurofins Scientific announces the acquisition of BioDiagnostics Inc. (BDI), seed and plant-tissue testing laboratories serving the agricultural industry in the US.Founded in 1996, BDI employs 120 staff at its laboratory in River Falls, WI. BDI offers genetic, seed quality, as well as analyt ... more

    Eurofins acquires of Boston Heart Diagnostics Corporation

    Eurofins Scientific announces the successful closing of the transaction to acquire Boston Heart Diagnostics Corp. (Boston Heart) following review and approval from relevant regulatory bodies.Eurofins signed an agreement to acquire Boston Heart for an initial cash amount US$140 million, plus ... more

    Eurofins successfully places EUR 500m new Euro bond

    Eurofins Scientific announced that it has successfully raised EUR 500m in its second senior unsecured Euro bond public issuance. The bonds have a seven-year maturity (due 27 January 2022) and will bear an annual coupon of 2.25% (ACT/ACT). The issue was more than three times over-subscribed. ... more

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE